If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
PRINCETON, N.J., Sept. 1 (HSMN NewsFeed) — Celator Pharmaceuticals, a privately held medical company developing new and more effective therapies to treat cancer based on the company’s proprietary technology, today announced that it raised $20 mil…
Biopharmaceuticals, Venture Capital
Celator Pharmaceuticals
Posts from ‘August, 2010’
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
Archimedes Pharmaceutical Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
READING, England, September 1, 2010 (HSMN NewsFeed) — Archimedes Pharma Ltd., a leading international specialty pharmaceutical company, today announced that the European Commission has granted product management authorisation for its lead product, PecFent*, an innovativ…
Biopharmaceuticals, Regulatory
Archimedes Pharma, PecFent, fentanyl nasal spray, breakthrough cancer pain
Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test
SAN DIEGO–(Healthcare Sales & Marketing Network)–Quidel Corporation (NASDAQ: QDEL ), a big provider of rapid diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA)…
Diagnostics, FDA
Quidel, RapidVue, hCG, human Chorionic Gonadotropin, pregnancy test
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
IRVINE, Calif.–(Healthcare Revenue & Marketing Network)–Allergan, Inc. (NYSE:AGN ) today announced the United States Food and Drug Administration (FDA) has approved LUMIGAN® (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for …
Biopharmaceuticals, Ophthalmology, FDA
Allergan, LUMIGAN, bimatoprost, intraocular pressure, glaucoma
Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
Fast-Growing Biosciences Company Forms Pharmaceutical Affairs Group, Headed by a 30-Year Veteran IRVING, Texas, Aug. 31, 2010 –(HSMN NewsFeed) — Caris Life Sciences(TM), Inc., a top biosciences company focused on enabling precise and personalized health…
Diagnostics, Personnel
Caris Life Sciences
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
FFR is updated to Class 1, level of evidence A, the highest class and level possible; update was driven by the positive results of the landmark FAME trial ST. PAUL, Minn.–(Healthcare Revenue & Marketing Network)–St. Jude Laboratory, Inc. (NYSE:STJ ) appla…
Devices, Interventional Cardiology
St. Jude Medical, PressureWire, Fractional Flow Reserve
SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
Proceeds to finance commercial ramp up of iFuse Implant System minimally invasive sacroiliac joint surgery device SAN JOSE, Calif., Aug. 17 (HSMN NewsFeed) — SI-BONE, Inc. (San Jose, California), a pharmaceutical device company that is pioneering the use of…
Devices, Orthopaedic, Neurosurgery, Venture Capital
SI-BONE, sacroiliac joint, iFuse Implant
BioMarin Acquires ZyStor Therapeutics, Inc.
High Affinity ZC-701 Fusion Enzyme Replacement Therapy Demonstrates Superior Potency and Efficacy to Myozyme in Nonclinical Studies Phase I/II Clinical Study In Late Onset Pompe Expected to Start in Q1 2011 Conference call and Webcast to Be Held Toda…
Biopharmaceuticals, Mergers & Acquisitions
BioMarin Pharma, ZyStor Therapeutics
Equinox Surgical Solutions Launches Flagship Product, SutureAssist(R)
New product improves surgeon and patient safety and contains facility costs RENO, Nev., Aug. 17 (HSMN NewsFeed) — Equinox Surgical Solutions LLC today announced the launch of their new product, SutureAssist®, designed and developed by a minimally…
Devices, Surgery
Equinox Surgical Solutions, SutureAssist
Medtronic Signs Agreement to Acquire Osteotech
Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business MEMPHIS, Tenn., Aug. 17 (HSMN NewsFeed) — Medtronic Inc., (NYSE:MDT ) and Osteotech, Inc., (Nasdaq:OSTE ) today announced that the companies have signed a defin…
Devices, Regenerative Medicine, Orthopaedic, Acquisitions
Medtronic, Osteotech, demineralized bone matrix, MagniFuse
